Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investors Events
  • Pre market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
November 15, 2024 7:01 AM 5 min read

Critical Insights From Confluent Analyst Ratings: What You Need To Know

by Benzinga Insights Benzinga Staff Writer
Follow
CFLT Logo
CFLTConfluent Inc
$30.48-0.29%
Overview

20 analysts have shared their evaluations of Confluent (NASDAQ:CFLT) during the recent three months, expressing a mix of bullish and bearish perspectives.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

Analysts have recently evaluated Confluent and provided 12-month price targets. The average target is $29.95, accompanied by a high estimate of $40.00 and a low estimate of $23.00. This upward trend is apparent, with the current average reflecting a 1.42% increase from the previous average price target of $29.53.

Diving into Analyst Ratings: An In-Depth Exploration

An in-depth analysis of recent analyst actions unveils how financial experts perceive Confluent. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

For valuable insights into Confluent's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.

Stay up to date on Confluent analyst ratings.

Get to Know Confluent Better

Confluent's Financial Performance

Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.

Positive Revenue Trend: Examining Confluent's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 24.99% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.

Net Margin: Confluent's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -29.63%, the company may face hurdles in effective cost management.

Return on Equity (ROE): Confluent's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of -8.2%, the company may face hurdles in generating optimal returns for shareholders.

Return on Assets (ROA): Confluent's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -2.89%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Confluent's debt-to-equity ratio stands notably higher than the industry average, reaching 1.19. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.

Understanding the Relevance of Analyst Ratings

Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.


Posted In:
Analyst RatingsBZI-AAR
Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 6 9 5 0 0
Last 30D 1 0 0 0 0
1M Ago 2 7 4 0 0
2M Ago 3 2 0 0 0
3M Ago 0 0 1 0 0
Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Mike Cikos Needham Maintains Buy $31.00 $31.00
Matthew Hedberg RBC Capital Raises Outperform $33.00 $26.00
Karl Keirstead UBS Raises Neutral $26.00 $23.00
Nick Altmann Scotiabank Raises Sector Perform $27.00 $25.00
Raimo Lenschow Barclays Raises Overweight $32.00 $29.00
Derrick Wood TD Cowen Raises Buy $31.00 $27.00
Gregg Moskowitz Mizuho Raises Outperform $31.00 $29.00
Mike Cikos Needham Raises Buy $31.00 $28.00
William Power Baird Raises Neutral $28.00 $23.00
Patrick Walravens JMP Securities Maintains Market Outperform $40.00 $40.00
Tyler Radke Citigroup Raises Neutral $25.00 $24.00
Pinjalim Bora JP Morgan Raises Overweight $26.00 $25.00
Peter Weed Bernstein Lowers Outperform $33.00 $38.00
Gregg Moskowitz Mizuho Lowers Outperform $29.00 $31.00
Patrick Walravens JMP Securities Maintains Market Outperform $40.00 $40.00
Mike Cikos Needham Maintains Buy $28.00 $28.00
Derrick Wood TD Cowen Lowers Buy $27.00 $31.00
Chirag Ved Evercore ISI Group Lowers Outperform $28.00 $33.00
Rudy Kessinger DA Davidson Maintains Buy $30.00 $30.00
William Power Baird Announces Neutral $23.00 -
  • Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Confluent. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Confluent compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Confluent's stock. This comparison reveals trends in analysts' expectations over time.

Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.

CFLT Logo
CFLTConfluent Inc
$30.48-0.29%
Overview
Comments
Loading...